Global Vaccine Industry

Global Vaccine (Include COVID-19) Industry Research & Trends Analysis Report

Global Vaccine Industry

Global Vaccine (Include COVID-19) Industry Research & Trends Analysis Report


Analysis of the Vaccine (Including COVID-19) Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to A Latest intelligence report published by Market IntelliX, the global market for Vaccine (Include COVID-19) should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Vaccine (Include COVID-19) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Vaccine (Include COVID-19) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Inactivated Vaccine segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Public has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Vaccine (Include COVID-19) include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and KM Biologics, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

This report aims to provide a comprehensive study of the global market for Vaccine (Include COVID-19). Report Highlights:

(1) Global Vaccine (Include COVID-19) market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Vaccine (Include COVID-19) market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Vaccine (Include COVID-19) market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Vaccine (Include COVID-19) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Vaccine (Include COVID-19) segment by type and by application and regional segment by type and by application.

(6) Vaccine (Include COVID-19) industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Inactivated Vaccine

Attenuated Vaccine

mRNA

Other

Market segment by application, can be divided into

Public

Private

Market segment by players, this report covers

Sanofi

CSL

GSK

Viatris

AstraZeneca

Hualan Bio

Changchun Institute of Biological

Sinovac

KM Biologics

Pfizer

Merck

Sinovac

Zhejiang Pukang

Walvax Biotechnology

Bharat Biotech

Serum Institute

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

LG Life Sciences

1 Market Overview

1.1 Product Overview and Scope of Vaccine (Include COVID-19)

1.2 Global Vaccine (Include COVID-19) Market Size and Forecast

1.3 China Vaccine (Include COVID-19) Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Vaccine (Include COVID-19) Share in Global Market, 2018-2029

1.4.2 Vaccine (Include COVID-19) Market Size: China VS Global, 2018-2029

1.5 Vaccine (Include COVID-19) Market Dynamics

1.5.1 Vaccine (Include COVID-19) Market Drivers

1.5.2 Vaccine (Include COVID-19) Market Restraints

1.5.3 Vaccine (Include COVID-19) Industry Trends

1.5.4 Vaccine (Include COVID-19) Industry Policy

2 Global Competitive Situation by Company

2.1 Global Vaccine (Include COVID-19) Revenue by Company (2018-2023)

2.2 Global Vaccine (Include COVID-19) Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Vaccine (Include COVID-19) Concentration Ratio

2.4 Global Vaccine (Include COVID-19) Mergers & Acquisitions, Expansion Plans

2.5 Global Vaccine (Include COVID-19) Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Vaccine (Include COVID-19) Revenue by Company (2018-2023)

3.2 China Vaccine (Include COVID-19) Vaccine (Include COVID-19) Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Vaccine (Include COVID-19), Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Vaccine (Include COVID-19) Industry Chain

4.2 Vaccine (Include COVID-19) Upstream Analysis

4.3 Vaccine (Include COVID-19) Midstream Analysis

4.4 Vaccine (Include COVID-19) Downstream Analysis

5 Sights by Type

5.1 Vaccine (Include COVID-19) Classification

5.1.1 Inactivated Vaccine

5.1.2 Attenuated Vaccine

5.1.3 mRNA

5.1.4 Other

5.2 By Type, Global Vaccine (Include COVID-19) Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Vaccine (Include COVID-19) Revenue, 2018-2029

6 Sights by Application

6.1 Vaccine (Include COVID-19) Segment by Application

6.1.1 Public

6.1.2 Private

6.2 By Application, Global Vaccine (Include COVID-19) Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Vaccine (Include COVID-19) Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Vaccine (Include COVID-19) Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Vaccine (Include COVID-19) Market Size, 2018-2029

7.3 North America

7.3.1 North America Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Vaccine (Include COVID-19) Market Size Market Share

7.4 Europe

7.4.1 Europe Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Vaccine (Include COVID-19) Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Vaccine (Include COVID-19) Market Size Market Share

7.6 South America

7.6.1 South America Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Vaccine (Include COVID-19) Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Vaccine (Include COVID-19) Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Vaccine (Include COVID-19) Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Vaccine (Include COVID-19) Market Size, 2018-2029

8.3.2 By Company, U.S. Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Vaccine (Include COVID-19) Market Size, 2018-2029

8.4.2 By Company, Europe Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Vaccine (Include COVID-19) Market Size, 2018-2029

8.5.2 By Company, China Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.5.3 By Type, China Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Vaccine (Include COVID-19) Market Size, 2018-2029

8.6.2 By Company, Japan Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Vaccine (Include COVID-19) Market Size, 2018-2029

8.7.2 By Company, South Korea Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Vaccine (Include COVID-19) Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Vaccine (Include COVID-19) Market Size, 2018-2029

8.9.2 By Company, India Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.9.3 By Type, India Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Vaccine (Include COVID-19) Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Sanofi

9.1.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.1.2 Sanofi Company Profile and Main Business

9.1.3 Sanofi Vaccine (Include COVID-19) Models, Specifications and Application

9.1.4 Sanofi Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.1.5 Sanofi Recent Developments

9.2 CSL

9.2.1 CSL Company Information, Head Office, Market Area and Industry Position

9.2.2 CSL Company Profile and Main Business

9.2.3 CSL Vaccine (Include COVID-19) Models, Specifications and Application

9.2.4 CSL Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.2.5 CSL Recent Developments

9.3 GSK

9.3.1 GSK Company Information, Head Office, Market Area and Industry Position

9.3.2 GSK Company Profile and Main Business

9.3.3 GSK Vaccine (Include COVID-19) Models, Specifications and Application

9.3.4 GSK Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.3.5 GSK Recent Developments

9.4 Viatris

9.4.1 Viatris Company Information, Head Office, Market Area and Industry Position

9.4.2 Viatris Company Profile and Main Business

9.4.3 Viatris Vaccine (Include COVID-19) Models, Specifications and Application

9.4.4 Viatris Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.4.5 Viatris Recent Developments

9.5 AstraZeneca

9.5.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

9.5.2 AstraZeneca Company Profile and Main Business

9.5.3 AstraZeneca Vaccine (Include COVID-19) Models, Specifications and Application

9.5.4 AstraZeneca Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.5.5 AstraZeneca Recent Developments

9.6 Hualan Bio

9.6.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position

9.6.2 Hualan Bio Company Profile and Main Business

9.6.3 Hualan Bio Vaccine (Include COVID-19) Models, Specifications and Application

9.6.4 Hualan Bio Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.6.5 Hualan Bio Recent Developments

9.7 Changchun Institute of Biological

9.7.1 Changchun Institute of Biological Company Information, Head Office, Market Area and Industry Position

9.7.2 Changchun Institute of Biological Company Profile and Main Business

9.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Models, Specifications and Application

9.7.4 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.7.5 Changchun Institute of Biological Recent Developments

9.8 Sinovac

9.8.1 Sinovac Company Information, Head Office, Market Area and Industry Position

9.8.2 Sinovac Company Profile and Main Business

9.8.3 Sinovac Vaccine (Include COVID-19) Models, Specifications and Application

9.8.4 Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.8.5 Sinovac Recent Developments

9.9 KM Biologics

9.9.1 KM Biologics Company Information, Head Office, Market Area and Industry Position

9.9.2 KM Biologics Company Profile and Main Business

9.9.3 KM Biologics Vaccine (Include COVID-19) Models, Specifications and Application

9.9.4 KM Biologics Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.9.5 KM Biologics Recent Developments

9.10 Pfizer

9.10.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.10.2 Pfizer Company Profile and Main Business

9.10.3 Pfizer Vaccine (Include COVID-19) Models, Specifications and Application

9.10.4 Pfizer Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.10.5 Pfizer Recent Developments

9.11 Merck

9.11.1 Merck Company Information, Head Office, Market Area and Industry Position

9.11.2 Merck Company Profile and Main Business

9.11.3 Merck Vaccine (Include COVID-19) Models, Specifications and Application

9.11.4 Merck Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.11.5 Merck Recent Developments

9.12 Sinovac

9.12.1 Sinovac Company Information, Head Office, Market Area and Industry Position

9.12.2 Sinovac Company Profile and Main Business

9.12.3 Sinovac Vaccine (Include COVID-19) Models, Specifications and Application

9.12.4 Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.12.5 Sinovac Recent Developments

9.13 Zhejiang Pukang

9.13.1 Zhejiang Pukang Company Information, Head Office, Market Area and Industry Position

9.13.2 Zhejiang Pukang Company Profile and Main Business

9.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Models, Specifications and Application

9.13.4 Zhejiang Pukang Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.13.5 Zhejiang Pukang Recent Developments

9.14 Walvax Biotechnology

9.14.1 Walvax Biotechnology Company Information, Head Office, Market Area and Industry Position

9.14.2 Walvax Biotechnology Company Profile and Main Business

9.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Models, Specifications and Application

9.14.4 Walvax Biotechnology Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.14.5 Walvax Biotechnology Recent Developments

9.15 Bharat Biotech

9.15.1 Bharat Biotech Company Information, Head Office, Market Area and Industry Position

9.15.2 Bharat Biotech Company Profile and Main Business

9.15.3 Bharat Biotech Vaccine (Include COVID-19) Models, Specifications and Application

9.15.4 Bharat Biotech Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.15.5 Bharat Biotech Recent Developments

9.16 Serum Institute

9.16.1 Serum Institute Company Information, Head Office, Market Area and Industry Position

9.16.2 Serum Institute Company Profile and Main Business

9.16.3 Serum Institute Vaccine (Include COVID-19) Models, Specifications and Application

9.16.4 Serum Institute Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.16.5 Serum Institute Recent Developments

9.17 Panacea Biotec Ltd

9.17.1 Panacea Biotec Ltd Company Information, Head Office, Market Area and Industry Position

9.17.2 Panacea Biotec Ltd Company Profile and Main Business

9.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Models, Specifications and Application

9.17.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.17.5 Panacea Biotec Ltd Recent Developments

9.18 Bio-Med

9.18.1 Bio-Med Company Information, Head Office, Market Area and Industry Position

9.18.2 Bio-Med Company Profile and Main Business

9.18.3 Bio-Med Vaccine (Include COVID-19) Models, Specifications and Application

9.18.4 Bio-Med Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.18.5 Bio-Med Recent Developments

9.19 Halfkin Bio-Pharmaceuticals

9.19.1 Halfkin Bio-Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.19.2 Halfkin Bio-Pharmaceuticals Company Profile and Main Business

9.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Models, Specifications and Application

9.19.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.19.5 Halfkin Bio-Pharmaceuticals Recent Developments

9.20 LG Life Sciences

9.20.1 LG Life Sciences Company Information, Head Office, Market Area and Industry Position

9.20.2 LG Life Sciences Company Profile and Main Business

9.20.3 LG Life Sciences Vaccine (Include COVID-19) Models, Specifications and Application

9.20.4 LG Life Sciences Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.20.5 LG Life Sciences Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Vaccine (Including COVID-19) Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Vaccine (Including COVID-19) Market trending toward high growth trajectories?
A dynamic process in the Vaccine (Including COVID-19) Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Pfizer, Moderna, AstraZeneca, GSK, Johnson & Johnson.
What is the Vaccine (Including COVID-19) Market really preparing for?
Companies in the Vaccine (Including COVID-19) Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
What important business segments are segregated by application types in the latest edition of the Vaccine (Including COVID-19) Market?
The key business segments in the Vaccine (Including COVID-19) Market are segregated by applications [Infectious Diseases, Travel Vaccinations, Pediatric Immunizations, Cancer Prevention] and types [mRNA, DNA, Recombinant, Inactivated].
What is the estimated size & growth rate of the Vaccine (Including COVID-19) Market?
In recent years, the Vaccine (Including COVID-19) Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
What does the future hold for the Vaccine (Including COVID-19) Market?
As the shift to value addition continues, companies in the Vaccine (Including COVID-19) Market face the dual challenge of improving interoperability to optimize performance and experience.
What is the estimated global market value of the Vaccine (Including COVID-19) Market?
The Vaccine (Including COVID-19) Market is expected to reach a considerable market valuation.